Question 1

How many shares of GSK1 does ARROWSTREET CAPITAL, LIMITED PARTNERSHIP own?

Accepted Answer

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP previously held 0 shares of GSK1 (GSK PLC) before exiting the position in 2022-Q3.

Question 2

What is ARROWSTREET CAPITAL, LIMITED PARTNERSHIP's GSK1 position worth?

Accepted Answer

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP's GSK1 position was last reported at $0 in 2022-Q3 before the exit.

Question 3

Is ARROWSTREET CAPITAL, LIMITED PARTNERSHIP buying or selling GSK1?

Accepted Answer

In 2022-Q3, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP exited their GSK1 position entirely (-100.0% change in shares).

Question 4

When did ARROWSTREET CAPITAL, LIMITED PARTNERSHIP first buy GSK1?

Accepted Answer

Based on available 13F filings, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP first reported a position in GSK1 in 2018-Q4. They have held the position across 16 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2022-Q3 Latest	Exited	0	-100.0%	$0	0.0%	—	0
2022-Q2	Increased	10M	+3.8%	$434.8M	0.6%	—	46
2022-Q1	Increased	9.6M	+32.5%	$419.1M	0.5%	—	56
2021-Q4	Increased	7.3M	+94.8%	$320.1M	0.4%	—	59
2021-Q3	Increased	3.7M	+107.4%	$142.4M	0.2%	—	58
2021-Q2	Decreased	1.8M	-34.8%	$71.6M	0.1%	—	0
2021-Q1	Decreased	2.8M	-62.0%	$98.4M	0.1%	—	0
2020-Q4	Increased	7.3M	+83.0%	$267.3M	0.4%	—	57
2020-Q3	Decreased	4M	-5.7%	$149.4M	0.2%	—	0
2020-Q2	Increased	4.2M	+42.6%	$171.7M	0.3%	—	49
2020-Q1	Decreased	3M	-30.7%	$111.9M	0.3%	—	0
2019-Q4	Decreased	4.3M	-14.7%	$200.2M	0.5%	—	0
2019-Q3	Decreased	5M	-8.9%	$213.2M	0.5%	—	0
2019-Q2	Decreased	5.5M	-46.4%	$219.4M	0.5%	—	0
2019-Q1	Increased	10.2M	+20.2%	$427.1M	1.0%	—	58
2018-Q4	New	8.5M	-	$325M	0.9%	—	60

GSGSK116 quarters

GSGSK1
16 quarters